Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis

Internal Medicine Journal

Volumn 42, Issue 2, 2012, Pages 191-198

  Limaye, V ^a,b   Hakendorf, P ^c   Woodman, R J ^c   Blumbergs, P ^d   Roberts Thomson, P ^e  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e Department of Immunology SA Health ^*  (Australia)

Author keywords

Bohan and Peter criteria; Dermatomyositis; Inclusion body myositis; Mortality; Polymyositis; Standardised mortality ratio

Indexed keywords

AUTOANTIBODY;

ACUTE CORONARY SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; APNEA; ARTICLE; AUSTRALIA; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; CONGESTIVE HEART FAILURE; DERMATOMYOSITIS; DIABETES MELLITUS; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INFECTION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; NEOPLASM; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; STANDARDIZED MORTALITY RATIO;

COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MYOSITIS; REGISTRIES; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA;

EID: 84857433621     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02406.x     Document Type: Article

References (40)

1. Limaye V, Blumbergs P, Roberts-Thomson PJ. Idiopathic Inflammatory myopathies. Intern Med J 2009; 39: 179-90.
2. Shanim EA, Rider LG, Pandey JP, O'Hanlon TP, Jara LJ, Samayoa EA etal. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 2002; 46: 1885-93.
3. Patrick M, Buchbinder R, Jolley D, Dennett X, Buchanan R. Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J Rheumatol 1999; 26: 1094-100.
4. O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M etal. Immunogenetic risk and protective factors for the idiopathic inflammatorymyopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006; 85: 111-27.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
6. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255-86.
7. Limaye V, Blumbergs P, Scott G, Roberts-Thomson P. The clinical features of dermatomyositis in a South Australian population. APLAR J Rheumatol 2007; 10: 86-93.
8. Oddis CV, Medsger TA. Clinical features, classification and epidemiology of inflammatory muscle disease. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology, 4th edn. Edinburgh: Mosby-Elsevier; 2008; 1433-48.
9. Lundberg IE, Forbess CJ. Mortality in idiopathic inflammatory myopathies. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S109-S114.
10. Medsger TA, Robinson H, Masi AT. Factors affecting survivorship in polymyositis: a life table study of 124 patients. Arthritis Rheum 1971; 14: 249-58.
11. Carpenter JR, Bunch TW, Engel AG, O'Brien PC. Survival in polymyositis: corticosteroids and risk factors. J Rheumatol 1977; 4: 207-14.
12. Cox S, Limaye VS, Hill C, Blumbergs P, Roberts-Thomson P. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 2010; 13: 117-24.
13. Hohlfeld R. Polymyositis and dermatomyositis. In: Karpati G, ed. Structural and Molecular Basis of Skeletal Muscle Diseases. Basel, Switzerland: ISN Neuropath Press; 2002; 221-7.
14. Limaye VS, Lester S, Blumbergs P, Roberts-thomson PJ. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis 2010; 13: 132-7.
15. Airo A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006; 25: 234-9.
16. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S35-S61.
17. Zochling J, Braun J. Mortality in ankylosing spondylitis. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S80-S84.
18. Kaprove RE, Little AH, Graham DC, Rosen PS. Ankylosing spondylitis: survival in men with and without radiotherapy. Arthritis Rheum 1980; 23: 57-61.
19. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993; 52: 174-6.
20. Radford EP, Doll R, Smith PG. Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med 1977; 297: 572-6.
21. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD etal. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2550-57.
22. Hissaria P, Lester S, Hakendorf P, Woodman R, Patterson K, Hill C etal. Survival in scleroderma: results from the population-based South Australian Register. Intern Med J 2011; 41: 381-90.
23. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B etal. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 2001; 28: 2230-37.
24. Torres C, Belmonte R, Carmona L, Gomez Reino FJ, Galindo M, Ramos B etal. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 2006; 39: 205-15.
25. Lynn SJ, Sawyers SM, Moller PW, O'Donnell JL, Chapman PT. Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001. Intern Med J 2005; 35: 170-73.
26. Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 1986; 15: 168-78.
27. Danko K, Pony A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 2004; 83: 35-52.
28. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstrern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer assisted analysis of ninety-two cases. Arthritis Rheum 1985; 28: 249-55.
29. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A Poor prognostic sign. Am J Med 1986; 80: 329-32.
30. Nicholls D. Dermatomyositis without creatine kinase elevation. Am J Med 1987; 83: 182-3.
31. Fafalak RG, Peterson MGE, Kagen LJ. Strength in polymyositis and dermatomyositis: best outcome in patients treated early. J Rheumatol 1994; 21: 643-8.
32. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 2002; 41: 22-6.
33. Bronner IM, van der Meluen MF, deVisser M, Kalmijn S, van Venrooij WJ, Voskuyl AE etal. Long term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006; 65: 1456-61.
34. Abou-Raya A, Abou-Raya S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 2006; 5: 331-7.
35. Marie I, Hachulla E, Cherin P, Hellot MF, Herson S, Levesque H etal. Opportunistic infection in polymyositis and dermatomyositis. Arthritis Rheum 2005; 53: 155-65.
36. Juarez M, Misischia R, Alarcon GS. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma and polymyositis/dermatomyositis. Rheum Dis Clin North Am 2003; 29: 163-84.
37. Maugars YM, Berthelot JMM, Abbas AA, Mussini JMB, Nguyen JMD, Prost AM. Long term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996; 14: 263-74.
38. Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R etal. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum 2006; 54: 2004-9.
39. Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E etal. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 2007; 56: 1295-303.
40. Chinoy H, Fertig N, Oddis CV, Ollier WER, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007; 66: 1345-9.